In contrast, inactivation of PHGDH improves the ROS level and stimulates HCC apoptosis upon sorafenib treatment, representing that targeting PHGDH may be an operational method to circumvent drug resistance in HCC (Wei et al., 2019). This evidence concerns the gene PHGDH and hepatocellular carcinoma.